Molecular Imaging 2017

Q3. Dose-painting trials

A. Could be performed on any valuable metabolic imaging B. Should be performed with metabolic imaging with a predictive value for post- radiotherapy relapse C. Require quality control D. Should be widely spread whatever the risk of « killing » the value of a metabolic imaging

47%

37%

11%

5%

A.

B.

C.

D.

MR spectroscopic imaging for dose-painting

27